SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Synsorb Biotech

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Zabrocki who wrote (9)1/16/1997 1:59:00 PM
From: Fred J Bealle   of 32
 
David, thanks for answering Bruce's query on shares issued & outstanding (15.5 mln).
The query about hospital pharmacies and inventories: if a hospital in Japan suddenly receives 200 banqueters with HUS from Sashimi, they will have time to order 200 doses of Synsorb Pk from a broker or even from the manufacturer, and have it airshipped within 24 hours. Nobody will die from HUS in 24 hours. (I didn't.)
So I do not see hospitals carrying 'justincase' inventories of 200x$5000 = $100 000 of this drug or any other. Maybe one sample might be kept at a major hospital.
For comparison, consider that snake venom antidotes are not kept at local hospitals---they are kept usually at regional hospitals. So somebody in a New York herpetarium hits bit by a cobra---he might have to wait a few hours for an antidote from hundreds of miles away.
-----------------------------------
Will this stock hit $25 in a year? Easily. I have been dithering for some time about buying back in at $10. I was hoping there would be a dip.
In a world of antibiotic-resistant drugs, Synsorb is a treasure beyond emeralds.
fred bealle
toronto
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext